Model of CRISPR, phage co-evolution explains confusing experimental results – Phys.Org
Phys.Org |
Model of CRISPR, phage co-evolution explains confusing experimental results
Phys.Org Beginning in 2012, scientists discovered they could use CRISPR proteins to precisely edit the genomes of not only bacteria but also of animals and humans. That discovery captured Science magazine’s Breakthrough of the Year in 2015 and could eventually … |
Phys.Org |
Model of CRISPR, phage co-evolution explains confusing experimental results
Phys.Org Beginning in 2012, scientists discovered they could use CRISPR proteins to precisely edit the genomes of not only bacteria but also of animals and humans. That discovery captured Science magazine’s Breakthrough of the Year in 2015 and could eventually … |
Phys.Org |
Scientists present the smallest member of the CRISPR-Cas9 family …
Phys.Org Comparison of Cas9 ‘gene scissors’ from different bacteria: Streptococcus pyogenes, Staphylococcus aureus and Campylobacter jejuni. The Cas9 protein … CRISPR And CRISPR-Associated (Cas) Genes Market To Reach …Medgadget (blog) |
|
Durable Perianal Fistula Remissions With Stem Cell Product
Medscape Clinical and radiologic remission of perianal fistulas was significantly better in patients treated with Cx601, a suspension of allogeneic expanded adipose-derived stem cells, than with placebo, said Julián Panés, MD, chief of gastroenterology at … |
Is stories |
Early-stage study validates Cellect Bio’s method of stem cell selection; shares ahead 19%
Seeking Alpha Thinly traded nano cap Cellect Biotechnology Ltd. (APOP +19.4%) jumps on more than a 4x surge in volume in response to its announcement of positive results from a Phase 1 study aimed at validating its proprietary method of stem cell selection called … Cellect Announces Positive Clinical Trial ResultsP&T Community |